BRVE peer analysis
Braveheart Bio (BRVE) against its competitors: price, today's move, 1-year return and market value side by side.
BRVE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BBIO BridgeBio Pharma | $78.61 | 0.87% | 27.20% | $15.31B |
| BCDA BioCardia | $0.90 | 6.19% | -30.57% | $13.66M |
| CYTK Cytokinetics | $56.22 | 1.96% | -6.55% | $7.82B |
| KARD Kardigan | $15.21 | 0.20% | – | $1.36B |
| RNA Atrium Therapeutics | $8.18 | -2.39% | -88.28% | $139.92M |
| TNYA Tenaya Therapeutics | $0.37 | -5.91% | -71.04% | $84.49M |
| BRVE Braveheart Bio | $19.46 | 4.62% | – | $1.37B |
- BRVE's peers: BBIO (BridgeBio Pharma), BCDA (BioCardia), CYTK (Cytokinetics), KARD (Kardigan), RNA (Atrium Therapeutics), TNYA (Tenaya Therapeutics).
Updated 2026-11-11 00:49 UTC